Tag: TRYPTYR
Alcon Announces U.S. Launch of TRYPTYR (acoltremon ophthalmic solution) 0.003%, a...
Alcon has announced the U.S. commercial availability of TRYPTYR® (acoltremon ophthalmic solution) 0.003%, the latest innovation for the treatment of the signs and symptoms...
Alcon Announces FDA Approval of TRYPTRY Drops for Dry Eye
Alcon has announced the U.S. Food and Drug Administration (FDA) has approved TRYPTYR® (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for the treatment...
